Table 2:
Characteristics of study population for all respondents and separately by sex
| All respondents | Female respondents | Male respondents | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean or % | SD | Med. | N | Mean or % | SD | Med. | N | Mean or % | SD | Med. | N | |
|
|
||||||||||||
| Demographic characteristics | ||||||||||||
| Female | 43.1% | -- | -- | 596 | 100% | -- | -- | 257 | 0% | -- | -- | 339 |
| Age, 2000 | 66.2 | 7.6 | 65.0 | 596 | 65.9 | 7.7 | 65.0 | 257 | 66.4 | 7.6 | 66.0 | 339 |
| Age, 2006 | 72.3 | 7.6 | 72.0 | 596 | 72.0 | 7.7 | 71.0 | 257 | 72.5 | 7.6 | 72.0 | 339 |
| Age, 2007 | 72.7 | 7.6 | 72.0 | 577 | 72.5 | 7.7 | 71.0 | 247 | 72.9 | 7.6 | 72.0 | 330 |
| Age, 2011 | 75.9 | 7.3 | 75.0 | 500 | 75.8 | 7.5 | 75.0 | 223 | 76.1 | 7.3 | 75.0 | 277 |
| Education, years | 5.7 | 4.7 | 6.0 | 596 | 3.7 | 4.2 | 3.0 | 257 | 7.1 | 4.5 | 6.0 | 339 |
| Current smoker, 2006 | 18.8% | -- | -- | 596 | 3.1% | -- | -- | 257 | 30.7% | -- | -- | 339 |
| Body mass index, 2006 | 24.6 | 3.6 | 24.4 | 596 | 25.2 | 3.8 | 25.0 | 257 | 24.2 | 3.3 | 24.1 | 339 |
| Body mass index >30, 2006 | 6.4% | -- | -- | 596 | 10.1% | -- | -- | 257 | 3.5% | -- | -- | 339 |
| Health assessments (range: 1–5 = poor to excellent) | ||||||||||||
| Interviewer-rated health, 2006 | 3.7 | 1.0 | 4.0 | 596 | 3.5 | 1.0 | 4.0 | 257 | 3.8 | 0.9 | 4.0 | 339 |
| Self-rated health, 2006 | 3.0 | 1.0 | 3.0 | 589 | 2.9 | 1.0 | 3.0 | 254 | 3.1 | 1.0 | 3.0 | 335 |
| Cognitive function score (range: 0–24) | ||||||||||||
| 2006 | 15.8 | 3.7 | 17.0 | 588 | 15.1 | 4.4 | 16.0 | 254 | 16.4 | 3.0 | 17.0 | 334 |
| 2007 | 15.5 | 3.9 | 16.0 | 570 | 14.6 | 4.5 | 16.0 | 245 | 16.3 | 3.1 | 17.0 | 325 |
| 2011 | 14.6 | 4.3 | 16.0 | 462 | 13.7 | 4.8 | 15.0 | 205 | 15.3 | 3.8 | 16.0 | 257 |
| Inflammation, 2000 | ||||||||||||
| C-reactive protein (mg/L) | 2.7 | 6.4 | 0.8 | 596 | 2.6 | 4.1 | 1.0 | 257 | 2.8 | 7.7 | 0.7 | 339 |
| Interleukin-6 (pg/L) | 3.1 | 4.3 | 2.1 | 596 | 3.2 | 5.4 | 2.2 | 257 | 3.0 | 3.3 | 2.0 | 339 |
| Soluble e-selectin (ng/mL) | 46.7 | 23.9 | 40.7 | 596 | 47.5 | 25.4 | 41.5 | 257 | 46.1 | 22.7 | 40.1 | 339 |
| Soluble intercellular adhesion molecule-1 (ng/mL) | 246.9 | 97.2 | 234.5 | 596 | 251.8 | 101.4 | 241.2 | 257 | 243.2 | 93.9 | 229.2 | 339 |
| White blood cell count (x 103/|iL) | 6.0 | 1.5 | 5.8 | 596 | 6.0 | 1.5 | 5.7 | 257 | 6.0 | 1.4 | 5.8 | 339 |
| Inflammation, 2006 | ||||||||||||
| C-reactive protein (mg/L) | 2.9 | 7.0 | 1.1 | 596 | 2.2 | 3.8 | 1.2 | 257 | 3.5 | 8.6 | 1.1 | 339 |
| Interleukin-6 (pg/L) | 4.3 | 8.6 | 2.7 | 596 | 3.7 | 4.1 | 2.7 | 257 | 4.7 | 10.8 | 2.8 | 339 |
| Soluble e-selectin (ng/mL) | 42.4 | 28.9 | 35.2 | 596 | 40.2 | 29.8 | 33.3 | 257 | 44.0 | 28.1 | 36.9 | 339 |
| Soluble intercellular adhesion molecule-1 (ng/mL) | 282.0 | 101.3 | 268.3 | 596 | 281.2 | 94.6 | 269.9 | 257 | 282.5 | 106.2 | 266.2 | 339 |
| White blood cell count (x 103/|iL) | 6.1 | 1.8 | 5.9 | 596 | 5.9 | 1.7 | 5.6 | 257 | 6.2 | 1.8 | 6.1 | 339 |
| Inflammation index | ||||||||||||
| 2000 | 0.00 | 1.00 | −0.05 | 596 | 0.00 | 1.00 | −0.05 | 257 | 0.00 | 1.00 | −0.08 | 339 |
| 2006 | 0.00 | 1.00 | −0.07 | 596 | 0.00 | 1.00 | −0.07 | 257 | 0.00 | 1.00 | −0.05 | 339 |
| Average of 2000 & 2006 | 0.00 | 0.89 | −0.05 | 596 | 0.00 | 0.92 | −0.06 | 257 | 0.00 | 0.88 | −0.03 | 339 |
| Change between 2000 & 2006 | 0.00 | 0.89 | −0.02 | 596 | 0.00 | 0.80 | 0.00 | 257 | 0.00 | 0.95 | −0.04 | 339 |